Thierry Conroy

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.6K citations · Full text

Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102

Laurent Bedenne, Pierre Michel, Olivier Bouché et al. · Journal of Clinical Oncology · 2007 · 1.2K citations · Full text

Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2

Jean‐Pierre Gérard, D. Azria, S. Gourgou-Bourgade et al. · Journal of Clinical Oncology · 2010 · 747 citations

XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal Cancer

Jim Cassidy, Josep Tabernero, Chris Twelves et al. · Journal of Clinical Oncology · 2004 · 522 citations · Full text

Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial

S. Gourgou-Bourgade, Caroline Mollévi, Françoise Desseigne et al. · Journal of Clinical Oncology · 2012 · 480 citations · Full text